These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 871240)

  • 41. Peripheral blood lymphocytes and breast cancer.
    McCredie JA; Inch WR; Sutherland RM
    Arch Surg; 1973 Aug; 107(2):162-5. PubMed ID: 4541665
    [No Abstract]   [Full Text] [Related]  

  • 42. Peripheral lymphocyte counts in breast carcinoma. An index of immune competence.
    Papatestas AE; Kark AE
    Cancer; 1974 Dec; 34(6):2014-7. PubMed ID: 4434330
    [No Abstract]   [Full Text] [Related]  

  • 43. Radiation-induced lymphocyte-immune deficiency. A factor in the increased visceral metastases and decreased hormonal responsiveness of breast cancer.
    Meyer KK
    Arch Surg; 1970 Aug; 101(2):114-21. PubMed ID: 5451189
    [No Abstract]   [Full Text] [Related]  

  • 44. Cellular immunity & prognosis of human mammary carcinoma.
    Abrol SK; Shinghal RN; Saha K
    Indian J Med Res; 1984 Feb; 79():199-206. PubMed ID: 6611308
    [No Abstract]   [Full Text] [Related]  

  • 45. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer.
    Ownby HE; Roi LD; Isenberg RR; Brennan MJ
    Cancer; 1983 Jul; 52(1):126-30. PubMed ID: 6850535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term follow-up of general immune competence in breast cancer. II. Sequential pre- and post-treatment levels: a 10 year study.
    Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
    Cancer Immunol Immunother; 1986; 21(1):6-11. PubMed ID: 3632917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Wasting syndrome in patients with carcinoma. Lymphocytopenia and function of lymphocyte in peripheral blood].
    Shirakami A; Miyoshi K
    Nihon Ketsueki Gakkai Zasshi; 1967 Feb; 30(1):35-45. PubMed ID: 6070239
    [No Abstract]   [Full Text] [Related]  

  • 48. Recovery of lymphocyte status after radiotherapy.
    Chamberlain SM; Short JH; Nias AH
    Clin Radiol; 1980 Jul; 31(4):427-32. PubMed ID: 6968262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lymphocyte number and the prognosis for tumor patients].
    Röding H; Böhm E; Sperling P; Hamann HJ
    Z Arztl Fortbild (Jena); 1979 Oct; 73(19-20):911-2. PubMed ID: 551558
    [No Abstract]   [Full Text] [Related]  

  • 50. Lymphocyte reactivity in patients with carcinoma of the breast and large bowel.
    Miller JJ; Gaffney PR; Rees JA; Symes MO
    Br J Cancer; 1975 Jul; 32(1):16-20. PubMed ID: 1236735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skin window reactivity to autologous breast cancer. An index of prognostically significant cell-mediated immunity.
    Black MM; Zachrau RE; Hankey BF; Wesley M
    Cancer; 1988 Jul; 62(1):72-83. PubMed ID: 3383122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depressed lymphocyte function in carcinoma of the breast.
    Whittaker MG; Clark CG
    Br J Surg; 1971 Oct; 58(10):717-20. PubMed ID: 5097945
    [No Abstract]   [Full Text] [Related]  

  • 53. Total lymphocyte-counts in breast cancer.
    Bainbridge ET; Ford CH; Newman CE
    Lancet; 1978 Jun; 1(8075):1203-4. PubMed ID: 77967
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term (5-11 years) follow-up of general immune competence in breast cancer. I. Pre-treatment levels with reference to micrometastasis.
    Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
    Cancer Immunol Immunother; 1986; 21(1):1-5. PubMed ID: 3632914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-treatment general immune competence and prognosis in breast cancer. A prospective 2-year follow-up.
    Teasdale C; Hillyard JW; Webster DJ; Bolton PM; Hughes LE
    Eur J Cancer (1965); 1979 Jul; 15(7):975-82. PubMed ID: 488155
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of the lymphocyte level in breast carcinoma].
    Ballaira L; Isoardi Pons A; Ligabue Stricker F
    Arch Sci Med (Torino); 1977; 134(1):29-32. PubMed ID: 871240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
    Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
    Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Breast recurrence after conservative treatment of cancers of the breast: predictive factors and prognostic significance].
    Chauvet B; Simon JM; Reynaud-Bougnoux A; Descamps P; Calais G; Lansac J; Bougnoux P; Le Floch O
    Bull Cancer; 1990; 77(12):1193-205. PubMed ID: 2081279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.